Central neuronal activation and pressor responses induced by circulating ANG II: Role of the brain aldosterone-"ouabain" pathway

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 299, Issue 2, 2010, Pages

  Huang, Bing S ^a   Ahmadi, Sara ^a   Ahmad, Monir ^a   White, Roselyn A ^a   Leenen, Frans H H ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

Aldosterone synthase inhibitor; Angiotensin II; Eplerenone; Fra like immunoreactivity; Telemetry

Indexed keywords

ALDOSTERONE; ALDOSTERONE ANTAGONIST; ALDOSTERONE SYNTHASE; ANGIOTENSIN II; CORTICOSTEROID ANTAGONIST; CORTICOSTERONE; DIGOXIN ANTIBODY F(AB) FRAGMENT; EPLERENONE; FAD 286; MINERALOCORTICOID RECEPTOR; OUABAIN; SPIRONOLACTONE; UNCLASSIFIED DRUG;

ALDOSTERONE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE MEASUREMENT; BRAIN LEVEL; CELL ACTIVATION; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CRANIAL NERVE; HEART RATE; HYPERTENSION; HYPOTHALAMUS; IMMUNOREACTIVITY; MALE; MEAN ARTERIAL PRESSURE; NERVE CELL; NEUROMODULATION; NONHUMAN; OSMOTIC MINIPUMP; PRESSOR RESPONSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SUBFORNICAL ORGAN; SUPRAOPTIC NUCLEUS; THALAMUS MIDLINE NUCLEUS;

ALDOSTERONE; ALDOSTERONE ANTAGONISTS; ALDOSTERONE SYNTHASE; ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; BRAIN; CARDENOLIDES; ENZYME INHIBITORS; HEART RATE; HYPOTHALAMUS; IMIDAZOLES; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOHISTOCHEMISTRY; INFUSION PUMPS, IMPLANTABLE; INFUSIONS, PARENTERAL; INFUSIONS, SUBCUTANEOUS; MALE; NEURAL PATHWAYS; NEURONS; PROTO-ONCOGENE PROTEINS C-FOS; PYRIDINES; RATS; RATS, WISTAR; RENIN-ANGIOTENSIN SYSTEM; SAPONINS; SPIRONOLACTONE; SUBFORNICAL ORGAN; TELEMETRY; TIME FACTORS;

EID: 77955462845     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00256.2010     Document Type: Article

References (52)

1. Budzikowski AS, Vahid-Ansari F, Leenen FH. Chronic activation of brain areas by high-sodium diet in Dahl salt-sensitive rats. Am J Physiol Heart Circ Physiol 274: H2046-H2052, 1998.
2. Budzikowski AS, Vahid-Ansari F, Robertson GS, Leenen FH. Patterns of neuronal activation during development of sodium sensitive hypertension in SHR. Hypertension 30: 1572-1577, 1997.
3. Crowley SD, Gurley SB, Herrera MJ, Ruiz P, Griffiths R, Kumar AP, Kim HS, Smithies O, Le TH, Coffman TM. Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc Natl Acad Sci USA 103: 17985-17990, 2006.
4. Davern PJ, Head GA. Fos-related antigen immunoreactivity after acute and chronic angiotensin II-induced hypertension in the rabbit brain. Hypertension 49: 1170-1177, 2007.
5. Fink GD. Long-term sympatho-excitatory effect of angiotensin II: a mechanism of spontaneous and renovascular hypertension. Clin Exp Pharmacol Physiol 24: 91-95, 1997.
6. Francis J, Weiss RM, Wei SG, Johnson AK, Beltz TG, Zimmerman K, Felder RB. Central mineralocorticoid receptor blockade improves volume regulation and reduces sympathetic drive in heart failure. Am J Physiol Heart Circ Physiol 281: H2241-H2251, 2001.
7. Gabor A, Leenen FH. Mechanisms in the PVN mediating local and central sodium-induced hypertension in Wistar rats. Am J Physiol Regul Integr Comp Physiol 296: R618-R630, 2009.
8. Garwitz ET, Jones AW. Aldosterone infusion into the rat and dose-dependent changes in blood pressure and arterial ionic transport. Hypertension 4: 374-381, 1982.
9. Geerling JC, Loewy AD. Aldosterone in the brain. Am J Physiol Renal Physiol 297: F559-F576, 2009.
10. 3H]dopa in various regions of the brain. J Neurochem 13: 655-669, 1966.
11. Gomez-Sanchez CE, Zhou MY, Cozza EN, Morita H, Foecking MF, Gomez-Sanchez EP. Aldosterone biosynthesis in the rat brain. Endocrinology 138: 3369-3373, 1997.
12. Gomez-Sanchez EP. The mammalian mineralocorticoid receptor: tying down a promiscuous receptor. Exp Physiol 95: 13-18, 2010.
13. Gomez-Sanchez EP, Ahmad N, Romero DG, Gomez-Sanchez CE. Is aldosterone synthesized within the rat brain? Am J Physiol Endocrinol Metab 288: E342-E346, 2005.
14. Gomez-Sanchez EP, Gomez-Sanchez CM, Plonczynski M, Gomez-Sanchez CE. Aldosterone synthesis in the brain contributes to Dahl salt-sensitive rat hypertension. Exp Physiol 95: 120-130, 2010.
15. Griffin SA, Brown WC, MacPherson F, McGrath JC, Wilson VG, Korsgaard N, Mulvany MJ, Lever AF. Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism. Hypertension 17: 626-635, 1991.
16. Hauger RL, Aguilera G, Catt KJ. Angiotensin II regulates its receptor sites in the adrenal glomerulosa zone. Nature 271: 176-178, 1978.
17. Hendel MD, Collister JP. Contribution of the subfornical organ to angiotensin II-induced hypertension. Am J Physiol Heart Circ Physiol 288: H680-H685, 2005.
18. Huang BS, Harmsen E, Yu H, Leenen FH. Brain ouabain-like activity and the sympathoexcitatory and pressor effects of central sodium in rats. Circ Res 71: 1059-1066, 1992.
19. Huang BS, Leenen FH. Both brain angiotensin II and "ouabain" contribute to sympathoexcitation and hypertension in Dahl S rats on high salt intake. Hypertension 32: 1028-1033, 1998.
20. + channels prevents sympathetic hyperactivity and improves cardiac function in rats post-MI. Am J Physiol Heart Circ Physiol 288: H2491-H2497, 2005.
21. + in Wistar rats. Am J Physiol Regul Integr Comp Physiol 295: R166-R172, 2008.
22. Huang BS, White RA, Ahmad M, Tan J, Jeng AY. Central infusion of aldosterone synthase inhibitor attenuates left ventricular dysfunction and remodeling in rats after myocardial infarction. Cardiovasc Res 81: 574-781, 2009.
23. Huang BS, White RA, Jeng AY, Leenen FH. Role of central nervous system aldosterone synthase and mineralocorticoid receptors in salt-induced hypertension in Dahl salt-sensitive rats. Am J Physiol Regul Integr Comp Physiol 296: R994-R1000, 2009.
24. Huang BS, Yuan B, Leenen FH. Chronic blockade of brain "ouabain" prevents sympathetic hyper-reactivity and impairment of acute baroreflex resetting in rats with congestive heart failure. Can J Physiol Pharmacol 78: 45-53, 2000.
25. Kanagy NL, Pawloski CM, Fink GD. Role of aldosterone in angiotensin II-induced hypertension in rats. Am J Physiol Regul Integr Comp Physiol 259: R102-R109, 1990.
26. Kang YM, Zhang ZH, Johnson RF, Yu Y, Beltz T, Johnson AK, Weiss RM, Felder RB. Novel effect of mineralocorticoid receptor antagonism to reduce proinflammatory cytokines and hypothalamic activation in rats with ischemia-induced heart failure. Circ Res 99: 758-766, 2006.
27. Kimura S, Zhang GX, Abe Y. Malfunction of vascular control in lifestyle-related diseases: oxidative stress of angiotensin II-induced hypertension: mitogen-activated protein kinases, and blood pressure regulation. J Pharmacol Sci 96: 406-410, 2004.
28. Lal A, Veinot JP, Ganten D, Leenen FH. Prevention of cardiac remodeling after myocardial infarction in transgenic rats deficient in brain angiotensinogen. J Mol Cell Cardiol 39: 521-529, 2005.
29. Lal A, Veinot JP, Leenen FH. Critical role of CNS effects of aldosterone in cardiac remodeling post myocardial infarction in rats. Cardiovasc Res 64: 437-447, 2004.
30. Li Q, Dale WE, Hasser EM, Blaine EH. Acute and chronic angiotensin hypertension: neural and nonneural components, time course, and dose dependency. Am J Physiol Regul Integr Comp Physiol 271: R200-R207, 1996.
31. Leenen FH. Brain mechanisms contributing to sympathetic hyperactivity and heart failure. Circ Res 101: 221-223, 2007.
32. Leenen FH, Huang BS, Yu H, Yuan B. Brain "ouabain" mediates sympathetic hyperactivity in congestive heart failure. Circ Res 77: 993-1000, 1995.
33. Leenen FH, Skarda V, Yuan B, White R. Changes in cardiac ANG II postmyocardial infarction in rats: effects of nephrectomy and ACE inhibitors. Am J Physiol Heart Circ Physiol 276: H317-H325, 1999.
34. Leenen FH, White R, Yuan B. Isoproterenol-induced cardiac hypertrophy: role of circulatory versus cardiac renin-angiotensin system. Am J Physiol Heart Circ Physiol 281: H2410-H2416, 2001.
35. Li YW, Dampney RA. Expression of Fos-like protein in brain following sustained hypertension and hypotension in conscious rabbits. Neuroscience 61: 613-634, 1994.
36. Lindley TE, Doobay MF, Sharma RV, Davisson RL. Superoxide is involved in the central nervous system activation and sympathoexcitation of myocardial infarction-induced heart failure. Circ Res 94: 402-409, 2004.
37. Luft FC, Wilcox CS, Unger T, Kühn R, Demmert G, Rohmeiss P, Ganten D, Sterzel RB. Angiotensin-induced hypertension in the rat. Sympathetic nerve activity and prostaglandins. Hypertension 14: 396-403, 1989.
38. Mellon SH, Griffin LD, Compagnone NA. Biosynthesis and action of neurosteroids. Brain Res Rev 37: 3-12, 2001.
39. 2+ transporters in arterial smooth muscle from ouabain-induced hypertensive rats. Am J Physiol Heart Circ Physiol 298: H263-H274, 2010.
40. Pullen MA, Brooks DP, Edwards RM. Characterization of the neutralizing activity of digoxin-specific Fab toward ouabain-like steroids. J Pharmacol Exp Ther 310: 319-325, 2004.
41. Rogerson FM, Yao Y, Smith BJ, Fuller PJ. Differences in the determinants of eplerenone, spironolactone and aldosterone binding to the mineralocorticoid receptor. Clin Exp Pharmacol Physiol 31: 704-709, 2004.
42. Schiffrin EL, Gutkowska J, Genest J. Effect of angiotensin II and deoxycorticosterone infusion on vascular angiotensin II receptors in rats. Am J Physiol Heart Circ Physiol 246: H608-H614, 1984.
43. Sgro S, Ferguson AV, Renaud LP. Subfornical organ-supraoptic nucleus connections: an electrophysiologic study in the rat. Brain Res 303: 7-13, 1984.
44. Vahid-Ansari F, Leenen FH. Pattern of neuronal activation in rats with CHF after myocardial infarction. Am J Physiol Heart Circ Physiol 275: H2140-H2146, 1998.
45. Viau V, Meaney MJ. The inhibitory effect of testosterone on hypothalamic- pituitary-adrenal responses to stress is mediated by the medial preoptic area. J Neurosci 16: 1866-1876, 1996.
46. Wang H, Huang BS, Leenen FH. Brain sodium channels and ouabain-like compounds mediate central aldosterone-induced hypertension Am J Physiol Heart Circ Physiol 285: H2516-H2523, 2003.
47. Wei SG, Yu Y, Zhang ZH, Weiss RM, Felder RB. Angiotensin II-triggered p44/42 mitogen-activated protein kinase mediates sympathetic excitation in heart failure rats. Hypertension 52: 342-350, 2008.
48. Yongue BG, Roy EJ. Endogenous aldosterone and corticosterone in brain cell nuclei of adrenal-intact rats: regional distribution and effects of physiological variations in serum steroids. Brain Res 436: 49-61, 1987.
49. Yu Y, Wei SG, Zhang ZH, Gomez-Sanchez E, Weiss RM, Felder RB. Does aldosterone upregulate the brain renin-angiotensin system in rats with heart failure? Hypertension 51: 727-733, 2008.
50. Zhang ZH, Kang YM, Yu Y, Wei SG, Schmidt TJ, Johnson AK, Felder RB. 11β-Hydrosteroid dehydrogenase type 2 activity in hypothalamic paraventricular nucleus modulates sympathetic excitation. Hypertension 48: 127-133, 2006.
51. Zhang ZH, Yu Y, Kang YM, Wei SG, Felder RB. Aldosterone acts centrally to increase brain renin-angiotensin system activity and oxidative stress in normal rats. Am J Physiol Heart Circ Physiol 294: H1067-H1074, 2008.
52. Zimmerman MC, Lazartigues E, Sharma RV, Davisson RL. Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system. Circ Res 95: 210-216, 2004.